Table 3 Characteristics of included studies
From: Laparoscopic versus open approach in gastrectomy for advanced gastric cancer: a systematic review
References | Year | Country | Study design | Study period | Male/female | Age | Tumor size | BMI | ASA (1:2:3) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L | O | L | O | L | O | L | O | ||||||
Huang et al. [14] | 2010 | Chi- | Cohort | 2007–2008 | 40/26 | 39/30 | 55.80 ± 9.21 | 56.37 ± 10.63 | - | – | – | ||
Cai et al [15] | 2011 | Chi- | RCT | 2008–2009 | 39/10 | 37/10 | 54.4 ± 10.6 | 52.6 ± 13.6 | 4.15 ± 2.03 | 4.32 ± 1.78 | 21.99 ± 3.29 | 22.87 ± 2.76 | – |
Scatizzi et al. [16] | 2011 | Italy | CCS | 2006–2009 | 14/16 | 16/14 | 70 ± 12 | 69 ± 10.75 | 5.6 ± 3 | 7.2 ± 2.25 | 22 ± 1 | 24 ± 6.5 | 8/25/17 |
Shuang et al [17] | 2011 | Chi- | CCS | 2005–2007 | 30/5 | 30/5 | 58 ± 10.5 | 59 ± 16 | – | 21 ± 3 | 23 ± 3 | – | |
Zhao et al. [18] | 2011 | Chi- | CCS | 2004–2009 | 248/98 | 221/92 | 51.43 ± 11.45 | 52.57 ± 12.37 | 4.4 ± 1.57 | 4.6 ± 1.72 | – | – | |
Chun et al. [20] | 2012 | Korea | CCS | 2004–2009 | 30/22 | 48/19 | 61.1 ± 12.6 | 60.8 ± 11.1 | 3.4 ± 1.6 | 4.0 ± 2.1 | 22.8 ± 2.8 | 22.9 ± 3.0 | – |
Hamabe et al. [21] | 2012 | Japan | Cohort | 2000–2009 | 47/19 | 70/31 | 66.3 | 64.2 | 3.54 | 4.05 | – | – | |
Kim et al. [22] | 2012 | Korea | CCS | 2006–2007 | 53/35 | 50/38 | 56.0 ± 13.5 | 59.0 ± 13.1 | 3.8 ± 2.2 | 5.2 ± 2.7 | 22.9 ± 3.0 | 22.5 ± 3.0 | – |
Moisan et al. [23] | 2012 | Chile | Cohort | 2003–2010 | 21/10 | 20/11 | 67 ± 13.5 | 67 ± 14 | 3.7 ± 1.975 | 4.5 ± 2.425 | 26 ± 2.75 | 25.5 ± 3.5 | 22/38/2 |
Bo et al. [24] | 2013 | Chi- | CCS | 2004–2010 | 82/35 | 80/37 | 54.5 ± 10.6 | 52.6 ± 13.6 | – | 21.1 ± 3.0 | 21.7 ± 3.8 | – | |
Gordon et al. [25] | 2012 | Japan | CCS | 1999–2010 | 18/48 | 39/93 | 63.95 ± 12.11 | 66.96 ± 11.86 | – | 22.84 ± 3.45 | 22.06 ± 3.33 | – | |
Lin et al. [26] | 2013 | Chi- | Cohort | 2008–2010 | 12/71 | 12/71 | 61.6 ± 10.3 | 61.1 ± 10.5 | 4.6 ± 2.1 | 4.4 ± 2.2 | 22.3 | 21.5 | – |
Shinohara et al. [27] | 2012 | Japan | Cohort | 1998–2008 | 129/57 | 85/38 | 61.4 ± 11.7 | 63.1 ± 9.9 | – | 21.5 ± 3.2 | 21.4 ± 3.3 | 173/127/9 | |
Fang et al. [28] | 2014 | Chi- | CCS | 2005–2009 | 78/9 | 78/9 | 57 ± 8.16 | 56 ± 7.66 | 4.4 ± 1.90 | 4.8 ± 1.50 | 23.3 ± 2.216 | 22.9 ± 2.216 | 69/81/24 |
Qiu et al. [29] | 2014 | Chi- | CCS | 2012–2013 | 25/5 | 22/12 | 74.4 ± 3.1 | 75.6 ± 3.0 | 4.1 ± 1.9 | 4.9 ± 2.6 | 21.6 ± 2.7 | 21.6 ± 3.0 | 2/45/17 |
Cui et al. [30] | 2015 | Chi- | RCT | 2010–2012 | 88/40 | 98/44 | 60.1 ± 12.6 | 57.5 ± 11.2 | – | 23.03 ± 3.61 | 23.66 ± 3.23 | – | |
Wu et al. [31] | 2015 | Chi- | CCS | 2010–2012 | 92/68 | 115/80 | 58.09 ± 10.87 | 58.61 ± 12.33 | – | 22.40 ± 3.85 | 22.20 ± 3.75 | – | |
Zhang et al. [32] | 2015 | Chi- | CCS | 2007–2014 | 57/29 | 61/25 | 62 ± 4.83 | 61 ± 4.00 | – | – | 107/49/16 | ||
Hao et al. [33] | 2016 | Chi- | CCS | 2004–2011 | 437/191 | 414/165 | 54.57 ± 14.46 | 55.66 ± 12.59 | – | – | 610/520/77 | ||
Hu et al. [34] | 2016 | Chi- | RCT | 2012–2014 | 380/129 | 346/174 | 56.5 ± 10.4 | 55.8 ± 11.1 | 4.0 ± 2.0 | 4.0 ± 2.1 | 22.7 ± 3.2 | 22.7 ± 3.2 | – |
Li1 et al. [35] | 2016 | Chi- | CCS | 2012–2014 | 54/47 | 53/48 | 57.7 ± 10.5 | 59.5 ± 10.1 | – | 23.7 ± 71.1 | 23.7 ± 1.0 | 57/106/39 | |
Li2 et al. [35] | 2016 | Chi- | RCT | 2012–2014 | 13/7 | 27/3 | 53.5 ± 9.2 | 56.0 ± 9.2 | 3.7 ± 1.9 | 2.5 ± 1.3 | 22.4 ± 3.7 | 23.0 ± 3.1 | 1/38/5 |
Lu et al. [37] | 2016 | Chi- | CCS | 2008–2015 | 39/22 | 37/24 | 59 ± 7.75 | 57 ± 6.75 | – | 19 ± 1.25 | 22 ± 2 | 88/26/8 | |
Zhang et al. [38] | 2016 | Chi- | CCS | 2009–2014 | 65/27 | 59/33 | 63 ± 5.66 | 65 ± 5.66 | – | 19 ± 1.66 | 22 ± 1.33 | 120/47/17 | |
Xu1 et al. [39] | 2017 | Chi- | CCS | 2007–2011 | 60/7 | 60/7 | 58.5 ± 10.5 | 57.7 ± 9.6 | 5.4 ± 2.3 | 5.8 ± 2.2 | 22.5 ± 3.2 | 22.6 ± 3.5 | 5/105/24 |
Zhang et al. [40] | 2017 | Chi- | Cohort | 2006–2008 | 63/48 | 69/50 | 57.2 ± 11.2 | 58.7 ± 12.1 | – | – | – | ||
Inokuchi et al. [41] | 2018 | Japan | CCS | 2001–2012 | 39/13 | 37/15 | 67 ± 10.25 | 68 ± 13 | – | 21.9 ± 3.65 | 22.1 ± 3.175 | 39/52/13 | |
Li3 et al. [42] | 2018 | Chi- | Cohort | 2007–2012 | 322/88 | 311/99 | – | – | – | – | |||
Park et al. [43] | 2018 | Korea | RCT | 2010–2011 | 69/31 | 65/31 | 58.6 | 60.1 | – | 23.7 ± 3.0 | 23.3 ± 3.1 | – | |
Shi et al. [44] | 2018 | Chi- | RCT | 2010–2012 | 120/42 | 105/55 | 55.23 ± 11.01 | 55.02 ± 10.79 | 4.28 ± 1.94 | 4.40 ± 1.97 | 20.7 ± 3.086 | 20.2 ± 2.948 | 161/128/33 |
Xu2 et al. [49] | 2018 | Chi- | Cohort | 2005–2012 | 342/88 | 595/173 | 55.6 ± 10.4 | 56.8 ± 10.6 | 4.7 ± 1.8 | 4.9 ± 1.8 | 22.4 ± 3.0 | 22.2 ± 3.2 | 165/873/157 |
Chan et al. [45] | 2019 | Hong Kong | Cohort | 2009–2017 | 35/19 | 110/57 | 70 ± 12.5 | 66 ± 9.5 | – | – | 13/136/71 | ||
Chen et al. [19] | 2012 | Chi- | CCS | 2008–2010 | 49/175 | 23/89 | 61.6 ± 10.6 | 60.8 ± 10.2 | 4.7 ± 2.0 | 4.4 ± 2.0 | 22.3 | 22 | 180/143/13 |
Kinoshita et al. [46] | 2019 | Japan | Cohort | 2008–2014 | 214/91 | 217/88 | 67.1 | 67.7 | – | 21.5 ± 3.1 | 21.6 ± 3.4 | 195/359/56 | |
Lee et al. [47] | 2019 | Korea | RCT | 2011–2015 | 333/127 | 321/137 | 59.9 ± 10.8 | 59.5 ± 11.6 | 4.5 ± 2.4 | 4.5 ± 2.2 | 23.5 ± 2.9 | 23.7 ± 2.3 | 445/431/42 |
Wang et al. [48] | 2019 | Chi- | RCT | 2014–2017 | 144/78 | 133/87 | 59.4 ± 12.6 | 60.6 ± 10.2 | 3.6 ± 1.8 | 3.9 ± 1.2 | 23.1 ± 3.1 | 23.5 ± 3.5 | 179/255/8 |